Adipotide (FTPP) Research & Studies
We track 8 published, PubMed-indexed studies for Adipotide (FTPP), spanning 2011 to 2022. The research below includes 7 research articles, 1 clinical trial.
These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
7
Research Articles
1
Clinical Trial
Fatty Liver/Adipose Tissue Dual-Targeting Nanoparticles with Heme Oxygenase-1 Inducer for Amelioration of Obesity, Obesity-Induced Type 2 Diabetes, and Steatohepatitis.
Research ArticleHong J, Kim YH|Adv Sci (Weinh)|2022
Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes.
Research ArticleSharma G, Hu C, et al.|Sci Transl Med|2020
Epigenetic Age Acceleration in Adolescence Associates With BMI, Inflammation, and Risk Score for Middle Age Cardiovascular Disease.
Research ArticleHuang RC, Lillycrop KA, et al.|J Clin Endocrinol Metab|2019
Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.
Clinical TrialPreiss D, Dawed A, et al.|Diabetes Obes Metab|2017
A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication.
Research ArticleHossen N, Kajimoto K, et al.|J Control Release|2013
Comment on "a peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys".
Research ArticleCriscione L|Sci Transl Med|2012
Rapid and weight-independent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endothelium.
Research ArticleKim DH, Sartor MA, et al.|Diabetes|2012
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.
Research ArticleBarnhart KF, Christianson DR, et al.|Sci Transl Med|2011